Skip to main content

Table 2 Univariate and multivariate analyses the risk of sarcopenia

From: Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer

Factors

Odds ratio for sarcopenia (95% CI)

Univariate analysis

p value

Multivariate analysis

p value

Age

    

 > 75/ ≤ 75

8.543 (4.056–17.998)

< 0.001*

10.035 (4.217–23.877)

< 0.001*

Sex

    

 Male/female

1.662 (0.846–3.266)

0.140

  

BMI, kg/m2

    

 ≥ 18.5/< 18.5

0.177 (0.085–0.369)

< 0.001*

0.144 (0.062–0.337)

< 0.001*

Anemia

    

 Yes/no

2.091 (1.032–4.235)

0.041*

1.607 (0.705–3.666)

0.259

Tumor location

    

 Corpus/cardia

1.012 (0.388–2.641)

0.980

  

 Pylorus/cardia

1.020 (0.426–2.441)

0.965

  

 Mixed or total/cardia

0.614 (0.070–5.415)

0.660

  

Tumor size

    

 ≥ 4.75/< 4.75

2.100 (1.079–4.086)

0.029*

1.975 (0.842–4.632)

0.118

Type of differentiation

    

 Moderate/well

1.151 (0.376–3.528)

0.805

  

 Poor/well

0.955 (0.274–3.337)

0.943

  

pTNM stage

    

 II/I

2.819 (1.046–7.595)

0.040*

2.639 (0.716–9.731)

0.145

 III/I

2.409 (1.040–5.580)

0.040*

1.905 (0.595–6.599)

0.278

Serum Cr/Cys C

    

 Low/high

0.336 (0.163–0.692)

0.003*

0.334 (0.144–0.773)

0.010*

  1. Asterisks indicate meaningful results
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us